Levotitan Tablet 40/5 mg

Adult dose

The recommended dosage of this medication is one tablet once daily, to be taken with water, regardless of meals. It is advisable to take it at the same time each day (e.g., in the morning). In cases of severe renal impairment, treatment should start at a lower dosage, with gradual dose adjustments. Mild to moderate liver impairment: the daily dose of telmisartan should not exceed 40 mg. In elderly patients aged 75 years and older, starting at a low dosage is recommended.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years old have not been established; therefore, its use is not recommended.

This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, and should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain medical conditions, such as severe liver impairment, patients with heart failure or heart problems, and patients with hypotension, among others. Patients with primary aldosteronism, certain heart valve diseases, liver impairment, gastrointestinal diseases, kidney problems, and the elderly should use this medication with caution. Side effects like dizziness or peripheral edema may occur frequently, and serious side effects may occur rarely, so if any abnormal symptoms arise, it is essential to consult a healthcare professional immediately. This medication should be avoided during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible, with a switch to alternative therapies. Due to the risk of hypotension, patients with fluid or salt deficiency should improve their condition before taking this medication and monitor their blood pressure closely during treatment. There is a risk of hyperkalemia, so regular monitoring of blood potassium levels is necessary, and caution is needed when used with potassium supplements or medications containing potassium. Patients with weakened kidney function should frequently check their kidney function and electrolyte status while taking this medication. This medication can interact with other antihypertensive agents or specific drugs, so patients must inform their healthcare provider of any other medications they are taking. Breastfeeding women should avoid taking this medication and it is not recommended for children or adolescents under 18 years of age. In case of overdose, hypotension, dizziness, and heart-related issues may arise; therefore, strict adherence to the prescribed dosage is crucial, and if any unusual symptoms occur, a visit to the hospital should be made immediately. This medication should be stored in a container that can block light and kept out of reach of children, and packaging should only be opened immediately prior to use.

Serious side effects

• Sepsis
• thrombocytopenia
• anaphylaxis
• syncope
• myocardial infarction
• ventricular tachycardia
• arrhythmia
• atrial fibrillation
• vasculitis
• dyspnea

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication should be stored in a tightly sealed container that can block light, at room temperature between 1°C and 30°C. This storage method helps maintain the medication's efficacy and safety.

Appearance

This is a white and light gray, double-convex oval tablet.

Package unit

30 tablets/box [10 tablets/PTP X 3]